DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Brightling CE, Bleecker ER, Erpenbeck VJ. et al.
LUSTER-1 and -2: Two randomized controlled trials of the prostaglandin D2.
receptor 2 antagonist, fevipiprant, in asthma. Clin Investig (Lond) 2019;
9: 55-63
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.